Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies (Q37129831)

18 August 2017

Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies (English)

1 reference

18 August 2017

1 reference

Joseph R Calabrese

1 reference

18 August 2017

Prashant Gajwani

1 reference

18 August 2017

David J Muzina

series ordinal

1 reference

18 August 2017

David E Kemp

series ordinal

1 reference

18 August 2017

Keming Gao

series ordinal

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

Neuropsychiatric Disease and Treatment

18 August 2017

1 reference

18 August 2017

1 reference

18 August 2017

1 reference

18 August 2017

847-853

1 reference

Effectiveness of adjunctive antidepressant treatment for bipolar depression

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656327

Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656327

Acute treatment of mania: an update on new medications

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656327

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656327

Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656327

A rating scale for depression

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656327

A rating scale for mania: reliability, validity and sensitivity

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656327

A New Depression Scale Designed to be Sensitive to Change

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656327

Tranylcypromine versus imipramine in anergic bipolar depression

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656327

Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656327

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656327

Differentiating moderate and severe depression using the Montgomery-Asberg depression rating scale (MADRS).

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656327

Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656327

Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656327

A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656327

Subsyndromal depression is associated with functional impairment in patients with bipolar disorder

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656327

The long-term natural history of the weekly symptomatic status of bipolar I disorder

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2656327

The emerging epidemiology of hypomania and bipolar II disorder

3 September 2018

1 reference

12 December 2020

Bipolar depression: an underestimated treatment challenge

1 reference

12 December 2020

Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants

1 reference

12 December 2020

Impact of depressive symptoms compared with manic symptoms in bipolar disorder: results of a U.S. community-based sample

1 reference

12 December 2020

Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-controlled study

1 reference

12 December 2020

Identifiers

1 reference

18 August 2017

PubMed publication ID

19300620

1 reference